Arcturus Therapeutics Holdings, Inc. (ARCT)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$15.82+1.67%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · ARCT
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||
| Revenues | 29.4 | 82.0 | 152.3 | 166.8 | 206.0 | 12.4 | 9.5 | 20.8 |
| Operating Expenses & Income | ||||||||
| R&D Expenses | 86.8 | 112.2 | 195.2 | 192.1 | 147.8 | 173.8 | 57.8 | 33.6 |
| Operating Income | (102.3) | (76.3) | (95.7) | (78.2) | 12.2 | (202.9) | (71.5) | (25.5) |
| Earnings from Continuing Operations | ||||||||
| EBT, Incl. Unusual Items | — | (65.8) | 81.1 | (27.9) | 10.6 | (203.7) | (72.1) | (26.0) |
| Income Tax Expense | — | — | (0.0) | 1.8 | 1.3 | — | — | — |
| Net Income | ||||||||
| Net Income | (93.3) | (65.8) | (80.9) | (29.7) | 9.3 | (203.7) | (72.1) | (26.0) |
| Per Share | ||||||||
| Basic EPS | (3.28) | (2.40) | (3.00) | (1.12) | 0.35 | (7.74) | — | — |
| Diluted EPS | (3.28) | (2.40) | (3.00) | (1.12) | 0.35 | (7.74) | — | — |
| Revenue per Share | 1.03 | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 28.4 | 27.4 | 27.0 | 26.6 | 26.4 | 26.3 | — | — |
| Diluted Weighted Avg Shares | 28.4 | 27.4 | 27.0 | 26.6 | 27.1 | 26.3 | — | — |
| Supplemental | ||||||||
| EBITDA | — | (73.2) | (92.1) | (75.2) | 13.7 | (201.7) | (70.6) | (24.8) |
| EBIT | (102.3) | (76.3) | (95.7) | (78.2) | 12.2 | (202.9) | (71.5) | (25.5) |
| Effective Tax Rate | — | — | — | -6.6% | 12.2% | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.